naltrexone has been researched along with Bulimia in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.67) | 18.7374 |
1990's | 9 (37.50) | 18.2507 |
2000's | 5 (20.83) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Billman, M; Essayli, J; Lane-Loney, S; Mahr, F; Roden, RC; Ryan, S; Vrana, K | 1 |
Adam, T; Dallman, M; Daubenmier, J; Epel, E; Hecht, FM; Kristeller, J; Lustig, RH; Woolley, J | 1 |
Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ | 1 |
Kim, JJ; Lardeux, S; Nicola, SM | 1 |
Hackett, D; Heal, DJ; Hutson, PH; Murray, F; Vickers, SP | 1 |
Fontenelle, LF; Piquet-Pessôa, M | 1 |
Meyer, F | 1 |
Jarosz, PA; Metzger, BL | 1 |
Bringer, J; Courtet, P; Raingeard, I; Renard, E | 1 |
Capone, C; Farren, CK; Grilo, CM; McKee, SA; O'Malley, SS; Rounsaville, BJ; Sinha, R; Wu, R | 1 |
Corwin, RL; Coupland, J; Ghosh, S; Rao, RE; Wojnicki, FH | 1 |
Kinzie, J; Luby, ED; Markham, KM; Marrazzi, MA | 1 |
Chatoor, I; Hartzler, J; Herman, BH | 1 |
Mitchell, JE; Raymond, N; Specker, S | 1 |
Bacon, JP; Kinzie, J; Luby, ED; Marrazzi, MA | 1 |
Kinzie, J; Luby, ED; Marrazzi, MA | 1 |
Kinzie, J; Luby, ED; Marrazzi, MA; Wroblewski, JM | 1 |
Fornai, F; Maremmani, I; Marini, G | 1 |
Neumeister, A; Winkler, A; Wöber-Bingöl, C | 1 |
Alger, SA; Bigaouette, JM; Howard, LJ; Michalek, AV; Schwalberg, MD | 1 |
Christenson, G; Huber, M; Jennings, J; Mitchell, JE; Morley, J; Pomeroy, C; Thomas, B | 1 |
Gold, MS; Jonas, JM | 2 |
Apfelbaum, M; Igoin-Apfelbaum, L | 1 |
2 review(s) available for naltrexone and Bulimia
Article | Year |
---|---|
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania | 2016 |
A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa.
Topics: Antidepressive Agents; Bulimia; Clinical Trials as Topic; Cognitive Behavioral Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithium Carbonate; Naltrexone | 1993 |
12 trial(s) available for naltrexone and Bulimia
Article | Year |
---|---|
An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.
Topics: Adolescent; Anorexia Nervosa; Binge-Eating Disorder; Bulimia; Bulimia Nervosa; Feeding and Eating Disorders; Humans; Naltrexone; Randomized Controlled Trials as Topic; Young Adult | 2022 |
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs | 2015 |
Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.
Topics: Blood Glucose; Bulimia; Diabetes Mellitus, Type 1; Energy Intake; Feeding and Eating Disorders; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Naltrexone; Narcotic Antagonists; Time Factors | 2004 |
Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
Topics: Adaptation, Psychological; Adult; Alcohol Drinking; Alcoholism; Attitude; Body Mass Index; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Feeding and Eating Disorders; Female; gamma-Glutamyltransferase; Humans; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Treatment Outcome | 2007 |
Binge eating disorder: response to naltrexone.
Topics: Adult; Bulimia; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Naltrexone; Placebos | 1995 |
Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations.
Topics: Adolescent; beta-Endorphin; Bulimia; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Motivation; Naltrexone; Patient Admission; Psychotherapy; Single-Blind Method; Thinking | 1994 |
Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa.
Topics: Adult; Anorexia Nervosa; Body Weight; Bulimia; Follow-Up Studies; Humans; Naltrexone; Placebo Effect; Time Factors; Treatment Outcome | 1995 |
A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia.
Topics: Adult; Bulimia; Feeding and Eating Disorders; Female; Follow-Up Studies; Humans; Longitudinal Studies; Naltrexone; Treatment Outcome | 1995 |
High-dose naltrexone and liver function safety.
Topics: Adult; Alanine Transaminase; Anorexia Nervosa; Aspartate Aminotransferases; Bulimia; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Middle Aged; Naltrexone; Narcotic Antagonists | 1997 |
Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects.
Topics: Adult; beta-Endorphin; Bulimia; Double-Blind Method; Female; Humans; Hyperphagia; Imipramine; Naltrexone; Obesity | 1991 |
A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia.
Topics: Adult; Bulimia; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Naltrexone; Psychiatric Status Rating Scales; Random Allocation | 1989 |
Naltrexone and bulimic symptoms.
Topics: Adolescent; Adult; Bulimia; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Naltrexone | 1987 |
10 other study(ies) available for naltrexone and Bulimia
Article | Year |
---|---|
A new biomarker of hedonic eating? A preliminary investigation of cortisol and nausea responses to acute opioid blockade.
Topics: Adiposity; Adult; Biomarkers; Body Mass Index; Bulimia; Cross-Sectional Studies; Eating; Energy Intake; Feeding Behavior; Female; Humans; Hydrocortisone; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Overweight; Receptors, Opioid; Surveys and Questionnaires | 2014 |
Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.
Topics: Analgesics, Opioid; Animals; Bulimia; Diet, High-Fat; Eating; Male; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats, Long-Evans; Receptors, Dopamine; Receptors, Opioid; Synaptic Transmission | 2015 |
Effects of lisdexamfetamine in a rat model of binge-eating.
Topics: Animals; Baclofen; Behavior, Animal; Benzazepines; Benzodiazepines; Body Weight; Bulimia; Disease Models, Animal; Eating; Feeding Behavior; Female; Idazoxan; Lisdexamfetamine Dimesylate; Naltrexone; Olanzapine; Prazosin; Prodrugs; Raclopride; Rats; Rats, Wistar; Rolipram | 2015 |
Alleviation of both binge eating and sexual dysfunction with naltrexone.
Topics: Alcoholism; Antidepressive Agents; Bulimia; Child; Child Abuse; Depression; Female; Heroin Dependence; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Sex Work; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Stress Disorders, Post-Traumatic | 2008 |
The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
Topics: Animals; Body Weight; Brain; Bulimia; Energy Intake; Feeding Behavior; Hyperphagia; Injections, Intraventricular; Models, Animal; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Zucker; Satiation | 2002 |
Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.
Topics: Animals; Baclofen; Bulimia; Dietary Fats; Dopamine Antagonists; Eating; Emulsions; Feeding Behavior; GABA Agonists; Male; Naltrexone; Narcotic Antagonists; Raclopride; Rats; Rats, Sprague-Dawley | 2008 |
Naltrexone-induced panic attacks.
Topics: Adult; Bulimia; Female; Humans; Naltrexone; Panic Disorder | 1998 |
Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
Topics: Adolescent; Bulimia; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 1999 |
Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse.
Topics: Adult; Brain; Bulimia; Feeding Behavior; Female; Humans; Naltrexone; Receptors, Opioid; Substance-Related Disorders | 1987 |
The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone.
Topics: Bulimia; Dose-Response Relationship, Drug; Humans; Naltrexone; Receptors, Opioid | 1988 |